In 2011, autoantibodies to several glycopeptides of MUC1, the protein recognized by the cancer antigens CA15-3 and CA27.29, were found to discriminate sera drawn from breast cancer patients at diagnosis from benign and healthy controls [16]. This evidence concerns the gene MUC1 and breast cancer.